Cytel News

Cytel has won Best Contract Research Organization( CRO) – Specialist Providers at the 2018 Scrip Awards. The accolade was presented to Cytel at an awards ceremony in London on 28th November 2018. The Scrip Awards acknowledge the pharmaceutical and biotechnology industry’s highest achievers across the value chain. The Best Contract Research Organization – Specialist Providers category highlights the critical role that CROs play in drug development, and particularly commends quality of service and strength of customer relationships. Cytel was selected as the winner by an independent panel of senior industry experts.

Cytel Inc., a global provider of advanced analytical solutions to the pharmaceutical, biotechnology, and medical device industries, today announced the launch of East® version 6.5, further enhancing the most trusted technology platform for designing, monitoring, and simulating adaptive trials.  Since 1995, East has empowered trial sponsors of all sizes to optimize study planning and monitoring efforts, accelerate timelines, and increase their probability of success in clinical development.

Congratulations to Lipopharma and the CLINGLIO project consortium on their recent 6,15M€ grant award by the European Union’s Horizon 2020 program. Led by Lipopharma, the multinational consortium brings together 12 academic and industry organizations from Europe, Israel, and the USA.

Cytel collaborated with Lipopharma and the consortium to create the innovative trial design and provided statistical input for the successful grant application.

Cytel is confirmed as a finalist in Most Innovative Trial Design and Best Sponsor-focused Technological Development categories at the Informa Clinical and Research Excellence Awards. The awards recognize innovation and excellence in the biopharma industry and Cytel is recognized for developments on East 6.4 and a innovative trial design created for sponsor Tracon Pharmaceuticals. The winners will be announced in April.